Cited by 142Thyroid Disorders and TreatmentsEstrogen and related hormone effectsGenomics and Chromatin Dynamics

A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene

Open access
Toyoda, Nagaoki, Zavacki, Ann Marie, Maia, Ana Luiza, Harney, John W., Larsen, P. Reed·1995·Molecular and Cellular Biology

Abstract

We identified two thyroid hormone response elements (TREs) in the 2.5-kb, 5'-flanking region of the human gene encoding type 1 iodothyronine deiodinase (hdio1), an enzyme which catalyses the activation of thyroxine to 3,5,3'-triiodothyronine (T3). Both TREs contribute equally to T3 induction of the homologous promoter in transient expression assays. The proximal TRE (TRE1), which is located at bp -100, has an unusual structure, a direct repeat of the octamer YYRGGTCA hexamer that is spaced by 10 bp. The pyrimidines in the -2 position relative to the core hexamer are both essential to function. In vitro binding studies of TRE1 showed no heterodimer formation with retinoid X receptor (RXR) beta or JEG nuclear extracts (containing RXR alpha) and bacterially expressed chicken T3 receptor alpha 1 (TR alpha) can occupy both half-sites although the 3' half-site is dominant. T3 causes dissociation of TR alpha from the 5' half-site but increases binding to the 3' half-site. Binding of a second TR to TRE1 is minimally cooperative; however, no cooperativity was noted for a functional mutant in which the half-sites are separated by 15 bp, implying that TRs bind as independent monomers. Nonetheless, T3 still causes TR dissociation from the DR+15, indicating that dissociation occurs independently of TR-TR contact and that rebinding of a T3-TR complex to the 3' half-site occurs because of its slightly higher affinity. A distal TRE (TRE2) is found at bp -700 and is a direct repeat of a PuGGTCA hexamer spaced by 4 bp. It has typical TR homodimer and TR-RXR heterodimer binding properties. The TRE1 of hdio1 is the first example of a naturally occurring TRE consisting of two relatively independent octamer sequences which do not require the RXR family of proteins for function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mcb.15.9.5100

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • T3 induces DIO1 transcription by binding to two TREs in the gene promoter in tissues including the liver.

    “T3 can induce DIO1 transcription by binding to two TREs in the gene promoter in tissues including the liver (34–36).”

    From Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion (2022) · cites this paper as [34]

    The paper reports two TREs in the human DIO1 promoter that contribute to T3 induction, and increased DIO1 mRNA after T3 exposure in HepG2 liver-derived cells. It says T3 binds the thyroid hormone receptor, which binds the TREs—not that T3 binds the TREs directly. The evidence for liver is from a liver-derived cell line, not liver tissue itself. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. [3]3. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84: 8573-8577.
  2. [4]4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. Wiley and Sons, New York.
  3. [24]24. Higuchi, R. 1990. Recombinant PCR, p. 177-183. In M. A. Innis, D. H. Gelf, and J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, Calif.
  4. [33]33. Koenig, R. J., G. A. Brent, R. L. Warne, P. R. Larsen, and D. D. Moore. 1987. Thyroid hormone receptor binds to a site in the rat growth promoter required for induction by thyroid hormone. Proc. Natl. Acad. Sci. USA 84: 5670-5674.
  5. [34]34. Koenig, R. J., R. L. Warne, G. A. Brent, J. W. Harney, P. R. Larsen, and D. D. Moore. 1988. Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor. Proc. Natl. Acad. Sci. USA 85: 5031-5035.
  6. [40]40. Leid, M., P. Kastner, R. Lyons, H. Nakshatri, M. Saunders, T. Zacharewski, J.-Y. Chen, A. Staub, J.-M. Garnier, S. Mader, and P. Chambon. 1992. Purification, cloning, and RXR identity of the HeLa cell factor which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377-395.
  7. [41]41. Maia, A. L., M. J. Berry, R. Sabbag, J. W. Harney, and P. R. Larsen. Structural functional differences in the Dio1 gene in mice with inherited type 1 deiodinase deficiency. Mol. Endocrinol., in press.
  8. [71]71. Williams, G. R., and G. A. Brent. 1994. Thyroid hormone response elements, p. 217-239. In B. Weintraub (ed.), Molecular endocrinology: basic concepts and clinical correlations. Raven Press, New York.

Cited by

Sorted by citations

Authors
Toyoda, N., Zavacki, A. M., Maia, A. L., Harney, J. W., & Larsen, P. R.
Affiliations
Brigham and Women's Hospital (US)
Venue
Molecular and Cellular Biology
Published
1995-09-01
Volume
15
Issue
9
Pages
5100-5112
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W1826361194
Cited by
142
References
1
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 8 · 2016: 3 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 5
FWCI
3.82
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • U.S. Public Health Service (44128)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
thyroid hormone response element, type 1 iodothyronine deiodinase, retinoid X receptor, transcriptional regulation, 5'-flanking region, receptor dissociation
MeSH terms
Base Sequence, Binding Sites, Humans, Iodide Peroxidase, Ligands, Molecular Sequence Data, Nuclear Proteins, Promoter Regions, Genetic, Protein Binding, Receptors, Thyroid Hormone, Repetitive Sequences, Nucleic Acid, Transcription Factors, Transcription, Genetic, Triiodothyronine, Genomic Library, Gene Expression Regulation, Enzymologic, Sequence Analysis, DNA, Receptors, Retinoic Acid, Retinoid X Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review